Who founded SOLA Biosciences?

SOLA Biosciences was founded by Keizo Koya, Akinori Hishiya in 2016.

Who are SOLA Biosciences's investors?

SOLA Biosciences's investors include Eisai Innovation, Inc., MC Healthcare Ventures, UTEC.

Where is SOLA Biosciences headquartered?

SOLA Biosciences is headquartered in Boston, US.

SOLA Biosciences

Boston, US · Founded 2016 · 4 employees on LinkedIn · 3 known investors

Find your way into SOLA Biosciences

Each arrow is one introduction. Sign up to fill in the first one.

21 people can intro you to Keizo

Ask Carrie Williams to introduce you to Keizo Koya

You →Carrie · together at Synta Pharmaceuticals →Keizo

Your email: who you already know at SOLA Biosciences, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SOLA Biosciences team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.

Biotech Deep Tech Medical Devices

Founders & leadership

SOLA Biosciences was founded in 2016 by Keizo Koya and Akinori Hishiya.

Keizo Koya Founder and CEOKeizo Koya has spent over four decades in pharmaceutical research and development across the U.S. and Japan, with training in synthetic organic chemistry and biology. He has led drug development programs spanning oncology, neurodegeneration, autoimmune, and metabolic diseases across small molecules, biologics, and gene therapies, and has founded multiple biotech ventures.

Akinori HishiyaFounder and CSF

Investors · 3

Eisai Innovation, Inc.listed by Eisai Innovation, Inc.Cambridge · $5M

MC Healthcare Ventureslisted by MC Healthcare VenturesCambridge

UTEClisted by UTECTokyo · $3.1M – $78M

How we know: UTEC's portfolio page · the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does SOLA Biosciences do?: SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.
Who founded SOLA Biosciences?: SOLA Biosciences was founded by Keizo Koya, Akinori Hishiya in 2016.
Who are SOLA Biosciences's investors?: SOLA Biosciences's investors include Eisai Innovation, Inc., MC Healthcare Ventures, UTEC.
Where is SOLA Biosciences headquartered?: SOLA Biosciences is headquartered in Boston, US.